SE418455B - Forfarande for framstellning av antibakteriellt verksamma preparat innehallande n-sulfanilyl-1-etylcytosin och en potentiator - Google Patents

Forfarande for framstellning av antibakteriellt verksamma preparat innehallande n-sulfanilyl-1-etylcytosin och en potentiator

Info

Publication number
SE418455B
SE418455B SE7415493A SE7415493A SE418455B SE 418455 B SE418455 B SE 418455B SE 7415493 A SE7415493 A SE 7415493A SE 7415493 A SE7415493 A SE 7415493A SE 418455 B SE418455 B SE 418455B
Authority
SE
Sweden
Prior art keywords
preparation
ethylycytosin
sulphanilyl
potentiator
procedure
Prior art date
Application number
SE7415493A
Other languages
English (en)
Swedish (sv)
Other versions
SE7415493L (fr
Inventor
E Bohni
M Montavon
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4425118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE418455(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE7415493L publication Critical patent/SE7415493L/xx
Publication of SE418455B publication Critical patent/SE418455B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE7415493A 1973-12-12 1974-12-10 Forfarande for framstellning av antibakteriellt verksamma preparat innehallande n-sulfanilyl-1-etylcytosin och en potentiator SE418455B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1740073 1973-12-12

Publications (2)

Publication Number Publication Date
SE7415493L SE7415493L (fr) 1975-06-13
SE418455B true SE418455B (sv) 1981-06-09

Family

ID=4425118

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7415493A SE418455B (sv) 1973-12-12 1974-12-10 Forfarande for framstellning av antibakteriellt verksamma preparat innehallande n-sulfanilyl-1-etylcytosin och en potentiator

Country Status (23)

Country Link
US (1) US3996357A (fr)
JP (1) JPS5089515A (fr)
AT (1) AT337890B (fr)
BE (1) BE823196A (fr)
BR (1) BR7410316A (fr)
CA (1) CA1043257A (fr)
CU (1) CU34136A (fr)
DD (1) DD117604A5 (fr)
DE (1) DE2455370C3 (fr)
DK (1) DK530674A (fr)
ES (1) ES432780A1 (fr)
FI (1) FI296474A (fr)
FR (1) FR2254346B1 (fr)
GB (1) GB1448040A (fr)
HU (1) HU169086B (fr)
IE (1) IE40295B1 (fr)
IL (1) IL45756A (fr)
LU (1) LU71448A1 (fr)
NL (1) NL7413331A (fr)
PH (1) PH11019A (fr)
SE (1) SE418455B (fr)
SU (1) SU573118A3 (fr)
ZA (1) ZA746108B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209513A (en) 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation

Also Published As

Publication number Publication date
ATA990274A (de) 1976-11-15
DE2455370C3 (de) 1980-02-07
FR2254346A1 (fr) 1975-07-11
ES432780A1 (es) 1976-12-16
FI296474A (fr) 1975-06-13
JPS5089515A (fr) 1975-07-18
LU71448A1 (fr) 1976-11-11
DE2455370A1 (de) 1975-06-19
IE40295L (en) 1975-06-12
FR2254346B1 (fr) 1978-02-03
AT337890B (de) 1977-07-25
BR7410316A (pt) 1976-06-22
CU34136A (fr) 1977-03-08
SE7415493L (fr) 1975-06-13
GB1448040A (en) 1976-09-02
SU573118A3 (ru) 1977-09-15
DK530674A (fr) 1975-08-18
CA1043257A (fr) 1978-11-28
US3996357A (en) 1976-12-07
ZA746108B (en) 1975-12-31
HU169086B (fr) 1976-09-28
IE40295B1 (en) 1979-04-25
NL7413331A (nl) 1975-06-16
IL45756A (en) 1977-05-31
PH11019A (en) 1977-10-25
IL45756A0 (en) 1974-11-29
BE823196A (fr) 1975-06-11
DD117604A5 (fr) 1976-01-20
AU7390774A (en) 1976-04-08
DE2455370B2 (de) 1979-06-07

Similar Documents

Publication Publication Date Title
SE408791B (sv) Forfarande och anordning for tillverkning av i verme formbart material
SE7706035L (sv) Framstellning av papper
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
EG11365A (en) Insecticides compounds of n-aminosulfenylated of carbofuran derivatives
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE421319B (sv) Forfarande for framstellning av etbara polysackarider och polysackaridderivat
SE417721B (sv) Forfarande for framstellning av fenol-aldehydskumplast
SE386823B (sv) Forfarande for framstellning av ett vattenhaltigt injicerbart preparat innehallande en sulfonamid och en potentiator
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
IT1017409B (it) Dispositivo per l approntamento di bobine avvolte
NO140928C (no) Fremgangsmaate for fremstilling av xylitol
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE405116B (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-imidazoler med bl a antibakteriell aktivitet
IT1046356B (it) Composti fosforati anfionici e procedimento per la loro preparazione
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
SE420622B (sv) Forfarande for framstellning av 6-aminopenicillansyra och enzymkomlex herfor
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE418455B (sv) Forfarande for framstellning av antibakteriellt verksamma preparat innehallande n-sulfanilyl-1-etylcytosin och en potentiator
SE404022B (sv) Forfarande for framstellning av heterocykliska sulfoxider och sulfoner
SE406095B (sv) Forgemnesbalndning och fergemneslosning innehallande minst tva isomerer av violetta substituerade naftylazofenylazonaftylfergemnen
SE7506588L (sv) Forfarande for framstellning av cefalosporiner och mellanprodukter
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
SE418295B (sv) Forfarande for framstellning av 6beta, 17-dihydroxi-7alfa-(legre alkoxikarbonyl-3-oxo-17alfa-pregn-4-en-21-karboxylsyra-gamma-laktoner och dermed beslektade foreningar